PMCR GmbH | Precision Medicine and Cancer Research
PMCR GmbH has developed new, precise, immunological therapy options for cancer patients with the involvement of leading experts from scientific and medical disciplines.
-
Client
PMCR GmbH | Precision Medicine and Cancer Research
-
Patents
9
-
Investment Need
2. million €
-
Tags
Financial planning, Investor Readiness, IP protection, white ip | Business Solutions, white ip | Patent & Legal
The business model is based on the latest scientific findings on the development and progression of this disease and its interaction with the body’s own immune defence system.
As part of the collaboration, the research results and developments achieved were legally patented by white ip | Patent & Legal in order to ensure the entrepreneurial development of the company on the basis of the invention and intellectual property.
In terms of business management, white ip | Business Solutions supported the company in setting up an efficient and professional corporate financial planning system to identify its financial capital requirements and develop its corporate planning.
In addition, the scientific data and business plans were organised and presented in an investor-friendly format. This included the creation of a one-pager and pitch deck, which emphasised the inventive added value of PMCR GmbH. The basis for this was a sharpened business model and an elaborated business plan.
A company valuation was also carried out on the basis of the key financial figures already compiled.